Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Tanja D de Gruijl"'
Autor:
Daniel J. Powell, Erik Hooijberg, Annelies W. Turksma, Tanja D. de Gruijl, S. Albelda, Megan M. Suhoski, Alfons J.M. van den Eertwegh, Anita G.M. Stam, Carl H. June, Winald R. Gerritsen, Rik J. Scheper, Saskia J. A. M. Santegoets
Publikováno v:
Journal of Translational Medicine, 11, pp. 37
Journal of Translational Medicine, 11, 37-37. BioMed Central
Journal of Translational Medicine
Santegoets, S J A M, Turksma, A W, Suhoski, M M, Stam, A G M, Albelda, S M, Hooijberg, E, Scheper, R J, van den Eertwegh, A J M, Gerritsen, W R, Powell, D J J, June, C H & de Gruijl, T D 2013, ' IL-21 promotes the expansion of CD27+CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells ', Journal of Translational Medicine, vol. 11, pp. 37-37 . https://doi.org/10.1186/1479-5876-11-37
Journal of Translational Medicine, 11, 37
Journal of Translational Medicine, 11, 37-37. BioMed Central
Journal of Translational Medicine
Santegoets, S J A M, Turksma, A W, Suhoski, M M, Stam, A G M, Albelda, S M, Hooijberg, E, Scheper, R J, van den Eertwegh, A J M, Gerritsen, W R, Powell, D J J, June, C H & de Gruijl, T D 2013, ' IL-21 promotes the expansion of CD27+CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells ', Journal of Translational Medicine, vol. 11, pp. 37-37 . https://doi.org/10.1186/1479-5876-11-37
Journal of Translational Medicine, 11, 37
Contains fulltext : 118572.pdf (Publisher’s version ) (Open Access) BACKGROUND: Adoptive cell transfer of tumor infiltrating lymphocytes has shown clinical efficacy in the treatment of melanoma and is now also being explored in other tumor types. G
Autor:
C. René Leemans, Tanja D. de Gruijl, Shakila Rampersad, Kirsten B.J. Scholten, Johanneke J. Akershoek, Erik Hooijberg, Chris J.L.M. Meijer, Annelies W. Turksma, Hetty J. Bontkes, Laura M Moesbergen, Saskia J. A. M. Santegoets, Saskia A.G.M. Cillessen, Janneke J. Ruizendaal
Publikováno v:
Turksma, A W, Bontkes, H J, Ruizendaal, J J, Scholten, K B J, Akershoek, J, Rampersad, S, Moesbergen, L M, Cillessen, S A G M, Santegoets, S J A M, de Gruijl, T D, Leemans, C R, Meijer, C J L M & Hooijberg, E 2013, ' Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients ', Journal of Translational Medicine, vol. 11, 152 . https://doi.org/10.1186/1479-5876-11-152
Journal of Translational Medicine, 11:152. BioMed Central
Journal of Translational Medicine, 11:152. BioMed Central
Background New treatment modalities are needed for the treatment of cancers of the head and neck region (HNSCC). Survivin is important for the survival and proliferation of tumor cells and may therefore provide a target for immunotherapy. Here we foc